Study of FYU-981 in Hyperuricemia With or Without Gout

NCT02416167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: FYU-981
DRUG: Placebo

Sponsor

Fuji Yakuhin Co., Ltd.